Medtronic MDT Reportable segment net sales — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medtronic's reportable segment net sales — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medtronic's reportable segment net sales — net sales?
- Medtronic (MDT) reported reportable segment net sales — net sales of $6.66B in Q1 2026.
- How has Medtronic's reportable segment net sales — net sales changed year-over-year?
- Medtronic's reportable segment net sales — net sales increased by 8.5% year-over-year, from $6.14B to $6.66B.
- What is the long-term trend for Medtronic's reportable segment net sales — net sales?
- Over 4 years (2022 to 2026), Medtronic's reportable segment net sales — net sales has grown at a 1.7% compound annual growth rate (CAGR), from $30.96B to $33.08B.
- What does reportable segment net sales — net sales mean?
- This metric represents the aggregate revenue generated from all of the company's primary business segments, excluding intersegment eliminations and corporate adjustments. It serves as a comprehensive measure of the top-line performance across the organization's core therapeutic and medical device product lines. By aggregating these segments, investors can assess the total market demand for the company's specialized medical technologies.